The Adhesion Barrier Market Size is valued at USD 610.72 Mn in 2022 and is predicted to reach USD 1146.97 Mn by the year 2031 at a 7.5% CAGR during the forecast period for 2023-2031.
An adhesion barrier is a surgical device intended to prevent the formation of adhesions. Adhesions are fibrous scar tissue bands that can form between organs and tissues following surgery or injury. Organs can become entangled due to these adhesions, resulting in persistent discomfort, intestinal blockage, and infertility. The increasing number of surgical procedures worldwide, particularly in gynaecology, abdominal, and orthopaedic surgery, has increased the demand for adhesion barriers. As surgical volumes rise, so does the need to prevent adhesion formation and accompanying problems.
Furthermore, the rising prevalence of sports-related injuries is likely to fuel market expansion. According to recent Stanford Children's Health data, more than 10% of the nearly 30 million children who participate in some sort of sports incur injuries each year.
However, the pandemic disrupted worldwide supply chains, disrupting medical device production and distribution, including adhesion obstacles. Manufacturing delays or raw material shortages may have influenced product availability.
The Adhesion Barrier Market is segmented on the basis of type, delivery mode, and application. Based on the Type, the market is segmented as synthetic adhesion barriers and natural adhesion barriers. The synthetic adhesion barriers segment includes hyaluronic acid, regenerated cellulose, polyethylene glycol, and others.
The natural adhesion barriers segment includes collagen & protein, and fibrin. By delivery mode, it is divided into film formulations, gel formulations, and liquid formulations. The applications segment includes gynaecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopaedic surgeries, urological surgeries, neurological surgeries, reconstructive surgeries, and others.
The synthetic adhesion barriers category is expected to hold a major share of the global Adhesion Barrier Market in 2022. This is due to its strong bioresorbability and biocompatibility. Synthetic adhesion barriers are inexpensive, which is projected to boost segment sales. Furthermore, the segment's dominance is partly due to the availability of commercial synthetic adhesion barriers. Because of their consistent quality, controlled production procedures, and predictable function, synthetic adhesion barriers have grown in popularity. As a result, there is a growing demand for these items in a variety of surgical specialities, including gynaecological, abdominal, and orthopaedic procedures.
The segment of cardiovascular surgeries is projected to grow at a rapid rate in the global Adhesion Barrier Market. The increased prevalence of cardiovascular disorders, as well as the increasing usage of adhesion barriers in cardiovascular procedures, are the primary drivers of growth in this section of the advanced adhesion barrier market. Adhesive disease is a leading cause of morbidity in postoperative patients. In gynaecological surgery, adhesion barriers have been shown to minimize adhesion-related problems. In open surgery, the use of adhesion barriers is cost-effective in reducing adhesion-related complications.
The North America Adhesion Barrier Market is expected to register the maximum market share in terms of revenue in the near future. The rising surgical rate in the region is well-documented. Technology innovation, senior patients demanding higher levels of function, and reimbursement methods incentivizing sophisticated fusion surgery are driving market expansion in North America. Adhesion barriers are also useful in oncology procedures.
Furthermore, rising public understanding of the benefits of surgical operations for injuries and chronic disease conditions is propelling market expansion. Over the projected period, the Asia Pacific adhesive barrier market is expected to rise at a rapid pace. The region's rapid rise is mostly due to an ageing population and an increase in cardiac and neurosurgical cases that necessitate surgical intervention.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 610.72 Mn |
| Revenue Forecast In 2031 | USD 1146.97 Mn |
| Growth Rate CAGR | CAGR of 7.5% from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, Delivery Mode, Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Baxter, Johnson & Johnson Private Limited, BD, Integra LifeSciences, Anika Therapeutics, Inc., Getinge AB, Terumo Corporation, FzioMed, Inc., MAST Biosurgery USA, Inc., Innocoll |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Adhesion Barrier Market By Type-
Adhesion Barrier Market By Delivery Mode-
Adhesion Barrier Market By Application-
Adhesion Barrier Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.